AstraZeneca plc

AstraZeneca plc is a leading global, science-led biopharmaceutical company headquartered in Cambridge, United Kingdom, that specializes in the discovery, development, and commercialization of prescription medicines. Formed in 1999 through the merger of Astra AB and Zeneca Group PLC, the company focuses on major therapeutic areas including oncology, rare diseases, and biopharmaceuticals covering cardiovascular, renal, metabolism, respiratory, and immunology. Operating in over 100 countries, AstraZeneca is committed to pushing the boundaries of science to deliver life-changing treatments and has gained significant prominence for its contributions to global health, including the development of a COVID-19 vaccine. The organization employs approximately 89,000 people and is recognized for its robust research and development pipeline and its strategic emphasis on sustainable healthcare and digital innovation.